US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Metagenomi Therapeutics Inc (MGX)
Metagenomi Therapeutics Inc (MGX) ニュース

Metagenomi Therapeutics Inc (MGX)

1.26

0.05

(4.13%)

終了 7月4日 5:00AM

1.24

-0.02

(-1.59%)

取引時間後: 8:28AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

EMERYVILLE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

On track for regulatory submission of MGX-001 to advance global clinical program, including investigational new...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

EMERYVILLE, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

jondoeuk

jondoeuk 1年前

(OT) New data from Dr. Liu's group. It is the result of more than three years of continuously improving CRISPR-associated transposases. A version, dubbed evoCAST, improves the editing efficiency from less than 0.1% of human cells to between ~10%-30% of cells.

One major hurdle of turning the evoCAST into a therapeutic solution that is able to insert large genes is the size and collective complexity of the seven proteins that comprise the system. But Dr. Liu said the scientists are working on streamlining the system further.

https://www.science.org/doi/10.1126/science.adt5199

tw0122

MGX $3.28 + 20% Gene editing AI play juice it $3.77-$4,03 in cards

theorysuit

theorysuit 1年前

LFG, she got her 2nd Wind!

theorysuit

theorysuit 2年前

1.81 to 4.92 with a normal retrace of 2.92. This stock still trades at under cash value. I have near to mid term fib targets of 6, 6.49, 6.87, 7.21, 7.58, 7.95, and 8.47 if you are looking for some exit points.

Landwehr

Landwehr 2年前

I enjoy the violatility of this stock. However, a news release will get us past 5.00 and into 6s

KIPK

A true theorySLUT paid to post theorySHIT on multiple massage boards..

KARMA in not a theory, Its a selftrap for good...

Landwehr

Landwehr 2年前

There hasn't been any news in a while. However, the chart is looking really good

Monksdream

Monksdream 2年前

MGX under $5

[color=red][/color]

Landwehr

Landwehr 2年前

MGX still looking good. A mild new release will send this to 4.5.

TrendTrade2016

TrendTrade2016 2年前

GAVE IT A CHANCE...SOLD IT

Landwehr

Landwehr 2年前

We need a news release for this to go back up. I'm long on this stock

TrendTrade2016

TrendTrade2016 2年前

MGX GAPPING BACK UP...LAST ATTEMPT

Landwehr

Landwehr 2年前

If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle.

TrendTrade2016

TrendTrade2016 2年前

5 DAY DOWN TREND SEEMS TO HAVE STOPPED

Landwehr

Landwehr 2年前

Very good consolidation while no new news

TrendTrade2016

TrendTrade2016 2年前

MGX BUILDING A FOUNDATION

Landwehr

Landwehr 2年前

The next news release will ignite this stock.

dinogreeves

dinogreeves 2年前

No, they are well funded well into 2025 and even beyond late 2025.

Millenium323

Millenium323 2年前

Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth

Landwehr

Landwehr 2年前

This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation

dinogreeves

dinogreeves 2年前

I sold at $4.50.

frans

MGX need money ???

frans

MGX company work for MM not for shaholders and selling shares into market

frans

all schort what I see on my L2 MM's 10 - 12 sametime

theorysuit

theorysuit 2年前

This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.

Landwehr

Landwehr 2年前

I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed

frans

I am not out I am long

theorysuit

theorysuit 2年前

Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.

Landwehr

Landwehr 2年前

frans

what is going on here ??

TrendTrade2016

TrendTrade2016 2年前

dinogreeves

dinogreeves 2年前

This is why it ran today with no news, someone knew it was coming

https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html

dinogreeves

dinogreeves 2年前

Corporate presentation just an hour ago.

https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf

dinogreeves

dinogreeves 2年前

Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much they’ll charge for a cure….. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.

dinogreeves

dinogreeves 2年前

https://metagenomi.co/discovery-platform

dinogreeves

dinogreeves 2年前

This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.

dinogreeves

dinogreeves 2年前

Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.

Monksdream

Monksdream 2年前

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock

Monksdream

Monksdream 2年前

UP OFF THE MAT, maybe it will grow legs

Landwehr

Landwehr 2年前

This could get to $5 this week

glenn1919

glenn1919 2年前

MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783

eur06

Just got on line….it looks pretty good!!
Trying to get some.

theorysuit

theorysuit 2年前

dinogreeves

dinogreeves 2年前

Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.

TrendTrade2016

TrendTrade2016 2年前

dinogreeves

dinogreeves 2年前

1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.

KIPK

POS ....You are

KIPK

You are a POS dude....

theorysuit

theorysuit 2年前

Added again here in full size. Data looks fantastic.

theorysuit

theorysuit 2年前

https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.

Metagenomi Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。